Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy
Authors
Keywords
P53, PTEN, P16, Osteosarcoma, Chemotherapy, Tissue Microarray, Tumor Suppressor Genes
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-08
DOI
10.1186/s12885-015-1397-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients
- (2015) Daniel Baumhoer et al. Oncotarget
- Maspin is not required for embryonic development or tumour suppression
- (2014) Sonia S. Y. Teoh et al. Nature Communications
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
- (2014) Xiang Chen et al. Cell Reports
- Maspin influences response to doxorubicin by changing the tumor microenvironment organization
- (2013) Tiziana Triulzi et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients
- (2013) Ayse Durnali et al. MEDICAL ONCOLOGY
- The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data
- (2013) Hongtao Li et al. PLoS One
- Prognostic significance of p53 expression in malignant bone tumors: a meta-analysis
- (2013) Liangdong Jiang et al. TUMOR BIOLOGY
- Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy
- (2012) Daliu Min et al. Asia-Pacific Journal of Clinical Oncology
- Different cellular p16INK4a localisation may signal different survival outcomes in head and neck cancer
- (2012) N Zhao et al. BRITISH JOURNAL OF CANCER
- An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy
- (2012) Emmanuel S. Antonarakis et al. CANCER
- p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
- (2012) James G. Jackson et al. CANCER CELL
- P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy
- (2012) Dariusz Borys et al. HUMAN PATHOLOGY
- Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
- (2012) Sveinung W. Sorbye et al. PLoS One
- Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials
- (2011) J. S. Whelan et al. ANNALS OF ONCOLOGY
- Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma
- (2011) Daniel Baumhoer et al. MODERN PATHOLOGY
- A prognostic evaluation of vascular endothelial growth factor in children and young adults with osteosarcoma
- (2011) Iwona Ługowska et al. PEDIATRIC BLOOD & CANCER
- Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma
- (2011) Zhihong Wu et al. PLoS One
- Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) P. C. W. Hogendoorn et al. ANNALS OF ONCOLOGY
- Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
- (2010) Barbara Rossi et al. BMC MUSCULOSKELETAL DISORDERS
- Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma
- (2010) Alexander B. Mohseny et al. GENES CHROMOSOMES & CANCER
- p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours
- (2010) Rooshdiya Z Karim et al. HISTOPATHOLOGY
- Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's Sarcoma Family of Tumors
- (2010) José Antonio López-Guerrero et al. INTERNATIONAL JOURNAL OF CANCER
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Expression change of ezrin as a prognostic factor in primary osteosarcoma
- (2010) Yao Fei Wang et al. MEDICAL ONCOLOGY
- The Tumor Suppressor Maspin Mediates E2F1-Induced Sensitivity of Cancer Cells to Chemotherapy
- (2010) B. Ben Shachar et al. MOLECULAR CANCER RESEARCH
- Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma
- (2010) Jarkko T. Korpi et al. SURGICAL ONCOLOGY-OXFORD
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
- Cyclooxygenase-2 Overexpression Predicts Poor Survival in Patients with High-grade Extremity Osteosarcoma: A Pilot Study
- (2009) Hiroshi Urakawa et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort
- (2009) Laura Ottaviano et al. GENES CHROMOSOMES & CANCER
- Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss ofCdkn2
- (2009) Alexander B Mohseny et al. JOURNAL OF PATHOLOGY
- VEGF expression as a prognostic marker in osteosarcoma
- (2009) Jyoti Bajpai et al. PEDIATRIC BLOOD & CANCER
- Copy number gains inEGFRand copy number losses inPTENare common events in osteosarcoma tumors
- (2008) Serena S. Freeman et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started